1
|
Kaiser R, Stark K. LNKing eosinophilia and atherothrombosis. Blood 2024; 143:1684-1686. [PMID: 38662388 DOI: 10.1182/blood.2023023530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2024] Open
Affiliation(s)
- Rainer Kaiser
- University Hospital Ludwig Maximilian University
- German Centre for Cardiovascular Research
| | - Konstantin Stark
- University Hospital Ludwig Maximilian University
- German Centre for Cardiovascular Research
| |
Collapse
|
2
|
Schaubaecher J, Smiljanov B, Haring F, Steiger K, Wu Z, Ugurluoglu A, Luft J, Ballke S, Mahameed S, Schneewind V, Hildinger J, Canis M, Mittmann L, Braun C, Zuchtriegel G, Kaiser R, Nicolai L, Mack M, Weichert W, Lauber K, Uhl B, Reichel CA. Procoagulant platelets promote immune evasion in triple negative breast cancer. Blood 2024:blood.2023022928. [PMID: 38648571 DOI: 10.1182/blood.2023022928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 04/03/2024] [Accepted: 04/08/2024] [Indexed: 04/25/2024] Open
Abstract
Triple-negative breast cancer (TNBC) is an aggressive tumor entity, in which immune checkpoint (IC) molecules are primarily synthesized in the tumor environment. Here, we report that procoagulant platelets bear large amounts of such immunomodulatory factors and that the presence of these cellular blood components in TNBC relates to pro-tumorigenic immune cell activity and impaired survival. Mechanistically, tumor-released nucleic acids attract platelets into the aberrant tumor microvasculature where they undergo procoagulant activation, thus delivering specific stimulatory and inhibitory IC molecules. This concomitantly promotes pro-tumorigenic myeloid leukocyte responses and compromises anti-tumorigenic lymphocyte activity, ultimately supporting tumor growth. Interference with platelet-leukocyte interactions prevented immune cell misguidance and suppressed tumor progression, nearly as effective as systemic IC inhibition. Hence, our data uncover a self-sustaining mechanism of TNBC in utilizing platelets to misdirect immune cell responses. Targeting this irregular multicellular interplay might represent a novel immunotherapeutic strategy in TNBC without side effects of systemic IC inhibition.
Collapse
Affiliation(s)
| | | | | | | | - Zhengquan Wu
- Ludwig-Maximilians-Universität München, Munich, Germany
| | | | | | | | | | | | | | | | | | | | | | - Rainer Kaiser
- Department of Medicine I, University Hospital, LMU Munich, Munich, Germany
| | - Leo Nicolai
- University Hospital, LMU Munich, Munich, Germany
| | | | | | | | - Bernd Uhl
- Ludwig-Maximilians-Universität München, Munich, Germany
| | | |
Collapse
|
3
|
Labeyrie G, Walker JGM, Robb GRM, Kaiser R, Ackemann T. Spontaneously Sliding Multipole Spin Density Waves in Cold Atoms. Phys Rev Lett 2024; 132:143402. [PMID: 38640397 DOI: 10.1103/physrevlett.132.143402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Revised: 02/27/2024] [Accepted: 03/11/2024] [Indexed: 04/21/2024]
Abstract
We report on the observation of spontaneously drifting coupled spin and quadrupolar density waves in the ground state of laser driven Rubidium atoms. These laser-cooled atomic ensembles exhibit spontaneous magnetism via light mediated interactions when submitted to optical feedback by a retroreflecting mirror. Drift direction and chirality of the waves arise from spontaneous symmetry breaking. The observations demonstrate a novel transport process in out-of-equilibrium magnetic systems.
Collapse
Affiliation(s)
- G Labeyrie
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - J G M Walker
- SUPA and Department of Physics, University of Strathclyde, Glasgow G4 0NG, Scotland, United Kingdom
| | - G R M Robb
- SUPA and Department of Physics, University of Strathclyde, Glasgow G4 0NG, Scotland, United Kingdom
| | - R Kaiser
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - T Ackemann
- SUPA and Department of Physics, University of Strathclyde, Glasgow G4 0NG, Scotland, United Kingdom
| |
Collapse
|
4
|
Kaiser R, Gold C, Joppich M, Loew Q, Akhalkatsi A, Mueller TT, Offensperger F, Droste Zu Senden A, Popp O, di Fina L, Knottenberg V, Martinez-Navarro A, Eivers L, Anjum A, Escaig R, Bruns N, Briem E, Dewender R, Muraly A, Akgöl S, Ferraro B, Hoeflinger JKL, Polewka V, Khaled NB, Allgeier J, Tiedt S, Dichgans M, Engelmann B, Enard W, Mertins P, Hubner N, Weckbach L, Zimmer R, Massberg S, Stark K, Nicolai L, Pekayvaz K. Peripheral priming induces plastic transcriptomic and proteomic responses in circulating neutrophils required for pathogen containment. Sci Adv 2024; 10:eadl1710. [PMID: 38517968 DOI: 10.1126/sciadv.adl1710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Accepted: 02/16/2024] [Indexed: 03/24/2024]
Abstract
Neutrophils rapidly respond to inflammation and infection, but to which degree their functional trajectories after mobilization from the bone marrow are shaped within the circulation remains vague. Experimental limitations have so far hampered neutrophil research in human disease. Here, using innovative fixation and single-cell-based toolsets, we profile human and murine neutrophil transcriptomes and proteomes during steady state and bacterial infection. We find that peripheral priming of circulating neutrophils leads to dynamic shifts dominated by conserved up-regulation of antimicrobial genes across neutrophil substates, facilitating pathogen containment. We show the TLR4/NF-κB signaling-dependent up-regulation of canonical neutrophil activation markers like CD177/NB-1 during acute inflammation, resulting in functional shifts in vivo. Blocking de novo RNA synthesis in circulating neutrophils abrogates these plastic shifts and prevents the adaptation of antibacterial neutrophil programs by up-regulation of distinct effector molecules upon infection. These data underline transcriptional plasticity as a relevant mechanism of functional neutrophil reprogramming during acute infection to foster bacterial containment within the circulation.
Collapse
Affiliation(s)
- Rainer Kaiser
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Christoph Gold
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Markus Joppich
- LFE Bioinformatik, Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Quentin Loew
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
| | | | - Tonina T Mueller
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
- Vascular Biology and Pathology, Institute of Laboratory Medicine, University Hospital Ludwig-Maximilians University, Munich, Germany
| | - Felix Offensperger
- LFE Bioinformatik, Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | | | - Oliver Popp
- Max Delbrück Center for Molecular Medicine (MDC) and Berlin Institute of Health (BIH), Berlin, Germany
| | - Lea di Fina
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | | | | | - Luke Eivers
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
| | - Afra Anjum
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Raphael Escaig
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Nils Bruns
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Eva Briem
- Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität, Munich, Germany
| | - Robin Dewender
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
| | - Abhinaya Muraly
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
| | - Sezer Akgöl
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Bartolo Ferraro
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig Maximilian University Munich, Planegg-Martinsried, Germany
| | - Jonathan K L Hoeflinger
- Vascular Biology and Pathology, Institute of Laboratory Medicine, University Hospital Ludwig-Maximilians University, Munich, Germany
| | - Vivien Polewka
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
| | - Najib Ben Khaled
- Medizinische Klinik und Poliklinik II, University Hospital Ludwig-Maximilian University, Munich, Germany
| | - Julian Allgeier
- Medizinische Klinik und Poliklinik II, University Hospital Ludwig-Maximilian University, Munich, Germany
| | - Steffen Tiedt
- Institute for Stroke and Dementia Research, University Hospital Ludwig-Maximilian University, Munich, Germany
| | - Martin Dichgans
- Institute for Stroke and Dementia Research, University Hospital Ludwig-Maximilian University, Munich, Germany
| | - Bernd Engelmann
- Vascular Biology and Pathology, Institute of Laboratory Medicine, University Hospital Ludwig-Maximilians University, Munich, Germany
| | - Wolfgang Enard
- Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität, Munich, Germany
| | - Philipp Mertins
- Max Delbrück Center for Molecular Medicine (MDC) and Berlin Institute of Health (BIH), Berlin, Germany
| | - Norbert Hubner
- Max Delbrück Center for Molecular Medicine (MDC) and Berlin Institute of Health (BIH), Berlin, Germany
- Charite-Universitätsmedizin Berlin, Berlin, Germany
- German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany
| | - Ludwig Weckbach
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
- Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig Maximilian University Munich, Planegg-Martinsried, Germany
| | - Ralf Zimmer
- LFE Bioinformatik, Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Steffen Massberg
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Konstantin Stark
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Leo Nicolai
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Kami Pekayvaz
- Department of Medicine I, LMU University Hospital, LMU Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| |
Collapse
|
5
|
Congy T, Azam P, Kaiser R, Pavloff N. Topological Constraints on the Dynamics of Vortex Formation in a Two-Dimensional Quantum Fluid. Phys Rev Lett 2024; 132:033804. [PMID: 38307046 DOI: 10.1103/physrevlett.132.033804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Accepted: 11/27/2023] [Indexed: 02/04/2024]
Abstract
We present experimental and theoretical results on formation of quantum vortices in a laser beam propagating in a nonlinear medium. Topological constrains richer than the mere conservation of vorticity impose an elaborate dynamical behavior to the formation and annihilation of vortex-antivortex pairs. We identify two such mechanisms, both described by the same fold-Hopf bifurcation. One of them is particularly efficient although it is not observed in the context of liquid helium films or stationary systems because it relies on the compressible nature of the fluid of light we consider and on the nonstationarity of its flow.
Collapse
Affiliation(s)
- T Congy
- Department of Mathematics, Physics and Electrical Engineering, Northumbria University, Newcastle upon Tyne NE1 8ST, United Kingdom
| | - P Azam
- Institut de Physique de Nice, Université Côte d'Azur, CNRS, F-06560 Valbonne, France
| | - R Kaiser
- Institut de Physique de Nice, Université Côte d'Azur, CNRS, F-06560 Valbonne, France
| | - N Pavloff
- Université Paris-Saclay, CNRS, LPTMS, 91405, Orsay, France
- Institut Universitaire de France (IUF)
| |
Collapse
|
6
|
Vanek P, Svoboda N, Bradac O, Malik J, Kaiser R, Netuka D. Clinical and radiological results of TLIF surgery with titanium-coated PEEK or uncoated PEEK cages: a prospective single-centre randomised study. Eur Spine J 2024; 33:332-338. [PMID: 37737497 DOI: 10.1007/s00586-023-07947-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2022] [Revised: 04/30/2023] [Accepted: 09/06/2023] [Indexed: 09/23/2023]
Abstract
BACKGROUND A comparison of fusion rates and clinical outcomes of instrumented transforaminal interbody fusion (TLIF) between polyetheretherketone (PEEK) and titanium-coated PEEK (Ti-PEEK) cages is not well documented. METHODS A single-centre, prospective, randomised study included patients who underwent one-level TLIF between L3-S1 segments. Patients were randomised into one of two groups: TLIF surgery with the PEEK cage and TLIF surgery with the Ti-PEEK cage. Clinical results were measured. All patients were assessed by repeated X-rays and 3D CT scans. Cage integration was assessed using a modified Bridwell classification. The impact of obesity and smoking on fusion quality was also analysed. Patients in both groups were followed up for 2 years. RESULTS Altogether 87 patients were included in the study: of these 87 patients, 81 (93.1%) completed the 2-year follow-up. A significant improvement in clinical outcome was found in the two measurements scales in both groups (RM: p = 0.257, VAS: p = 0.229). There was an increase in CobbS and CobbL angle in both groups (p = 0.172 for CobbS and p = 0.403for CobbL). Bony fusion was achieved in 37 of 40 (92.5%) patients in the TiPEEK group and 35 of 41 (85.4%) in the PEEK group (p = 0.157). Cage subsided in 2 of 40 patients (5%) in the TiPEEK group and 11 of 41 (26.8%) in the PEEK group (p = 0.007). Body mass index > 30 and smoking were not predictive factors of bony fusion achievement. CONCLUSION There is no significant advantage of TiPEEK cages over PEEK cages in clinical outcome and fusion rate 2 years after surgery.
Collapse
Affiliation(s)
- P Vanek
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
| | - N Svoboda
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic.
| | - O Bradac
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
| | - J Malik
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
| | - R Kaiser
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
| | - D Netuka
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
| |
Collapse
|
7
|
Kaiser R, Escaig R, Nicolai L. Hemostasis without clot formation: how platelets guard the vasculature in inflammation, infection, and malignancy. Blood 2023; 142:1413-1425. [PMID: 37683182 DOI: 10.1182/blood.2023020535] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/23/2023] [Accepted: 08/23/2023] [Indexed: 09/10/2023] Open
Abstract
Platelets are key vascular effectors in hemostasis, with activation signals leading to fast recruitment, aggregation, and clot formation. The canonical process of hemostasis is well-characterized and shares many similarities with pathological thrombus formation. However, platelets are also crucially involved in the maintenance of vascular integrity under both steady-state and inflammatory conditions by ensuring blood vessel homeostasis and preventing microbleeds. In these settings, platelets use distinct receptors, signaling pathways, and ensuing effector functions to carry out their deeds. Instead of simply forming clots, they mainly act as individual sentinels that swiftly adapt their behavior to the local microenvironment. In this review, we summarize previously recognized and more recent studies that have elucidated how anucleate, small platelets manage to maintain vascular integrity when faced with challenges of infection, sterile inflammation, and even malignancy. We dissect how platelets are recruited to the vascular wall, how they identify sites of injury, and how they prevent hemorrhage as single cells. Furthermore, we discuss mechanisms and consequences of platelets' interaction with leukocytes and endothelial cells, the relevance of adhesion as well as signaling receptors, in particular immunoreceptor tyrosine-based activation motif receptors, and cross talk with the coagulation system. Finally, we outline how recent insights into inflammatory hemostasis and vascular integrity may aid in the development of novel therapeutic strategies to prevent hemorrhagic events and vascular dysfunction in patients who are critically ill.
Collapse
Affiliation(s)
- Rainer Kaiser
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig Maximilian University, Munich, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung e.V., Partner Site Munich Heart Alliance, Munich, Germany
| | - Raphael Escaig
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig Maximilian University, Munich, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung e.V., Partner Site Munich Heart Alliance, Munich, Germany
| | - Leo Nicolai
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig Maximilian University, Munich, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung e.V., Partner Site Munich Heart Alliance, Munich, Germany
| |
Collapse
|
8
|
Pekayvaz K, Gold C, Hoseinpour P, Engel A, Martinez-Navarro A, Eivers L, Coletti R, Joppich M, Dionísio F, Kaiser R, Tomas L, Janjic A, Knott M, Mehari F, Polewka V, Kirschner M, Boda A, Nicolai L, Schulz H, Titova A, Kilani B, Lorenz M, Fingerle-Rowson G, Bucala R, Enard W, Zimmer R, Weber C, Libby P, Schulz C, Massberg S, Stark K. Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation. Immunity 2023; 56:2325-2341.e15. [PMID: 37652021 PMCID: PMC10588993 DOI: 10.1016/j.immuni.2023.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Revised: 06/23/2023] [Accepted: 08/03/2023] [Indexed: 09/02/2023]
Abstract
Maladaptive, non-resolving inflammation contributes to chronic inflammatory diseases such as atherosclerosis. Because macrophages remove necrotic cells, defective macrophage programs can promote chronic inflammation with persistent tissue injury. Here, we investigated the mechanisms sustaining vascular macrophages. Intravital imaging revealed a spatiotemporal macrophage niche across vascular beds alongside mural cells (MCs)-pericytes and smooth muscle cells. Single-cell transcriptomics, co-culture, and genetic deletion experiments revealed MC-derived expression of the chemokines CCL2 and MIF, which actively preserved macrophage survival and their homeostatic functions. In atherosclerosis, this positioned macrophages in viable plaque areas, away from the necrotic core, and maintained a homeostatic macrophage phenotype. Disruption of this MC-macrophage unit via MC-specific deletion of these chemokines triggered detrimental macrophage relocalizing, exacerbated plaque necrosis, inflammation, and atheroprogression. In line, CCL2 inhibition at advanced stages of atherosclerosis showed detrimental effects. This work presents a MC-driven safeguard toward maintaining the homeostatic vascular macrophage niche.
Collapse
Affiliation(s)
- Kami Pekayvaz
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
| | - Christoph Gold
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Parandis Hoseinpour
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Anouk Engel
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | | | - Luke Eivers
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Raffaele Coletti
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Markus Joppich
- Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Flávio Dionísio
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Rainer Kaiser
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Lukas Tomas
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Aleksandar Janjic
- Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Munich, Germany
| | - Maximilian Knott
- Institute of Pathology, Ludwig-Maximilian University Munich, Munich, Germany
| | - Fitsumbirhan Mehari
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Vivien Polewka
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Megan Kirschner
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Annegret Boda
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Leo Nicolai
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Heiko Schulz
- Institute of Pathology, Ludwig-Maximilian University Munich, Munich, Germany
| | - Anna Titova
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Badr Kilani
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | - Michael Lorenz
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany
| | | | - Richard Bucala
- Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
| | - Wolfgang Enard
- Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Munich, Germany
| | - Ralf Zimmer
- Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Christian Weber
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillian-Universität (LMU) München, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands
| | - Peter Libby
- Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
| | - Christian Schulz
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Steffen Massberg
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Konstantin Stark
- Medizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
| |
Collapse
|
9
|
Kaiser R, Anjum A, Kammerer L, Loew Q, Akhalkatsi A, Rossaro D, Escaig R, Droste zu Senden A, Raude B, Lorenz M, Gold C, Pekayvaz K, Brocker T, Kranich J, Holch JW, Spiekermann K, Massberg S, Gaertner F, Nicolai L. Mechanosensing via a GpIIb/Src/14-3-3ζ axis critically regulates platelet migration in vascular inflammation. Blood 2023; 141:2973-2992. [PMID: 37018659 PMCID: PMC10646815 DOI: 10.1182/blood.2022019210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 02/17/2023] [Accepted: 03/05/2023] [Indexed: 04/07/2023] Open
Abstract
Platelets are not only the first responders in thrombosis and hemostasis but also central players in inflammation. Compared with platelets recruited to thrombi, immune-responsive platelets use distinct effector functions including actin-related protein complex 2/3-dependent migration along adhesive substrate gradients (haptotaxis), which prevents inflammatory bleeding and contributes to host defense. How platelet migration in this context is regulated on a cellular level is incompletely understood. Here, we use time-resolved morphodynamic profiling of individual platelets to show that migration, in contrast to clot retraction, requires anisotropic myosin IIa-activity at the platelet rear which is preceded by polarized actin polymerization at the front to initiate and maintain migration. Integrin GPIIb-dependent outside-in signaling via Gα13 coordinates polarization of migrating platelets to trigger tyrosine kinase c-Src/14-3-3ζ-dependent lamellipodium formation and functions independent of soluble agonists or chemotactic signals. Inhibitors of this signaling cascade, including the clinically used ABL/c-Src inhibitor dasatinib, interfere predominantly with the migratory capacity of platelets, without major impairment of classical platelet functions. In murine inflammation models, this translates to reduced migration of platelets visualized by 4D intravital microscopy, resulting in increased inflammation-associated hemorrhage in acute lung injury. Finally, platelets isolated from patients with leukemia treated with dasatinib who are prone to clinically relevant hemorrhage exhibit prominent migration defects, whereas other platelet functions are only partially affected. In summary, we define a distinct signaling pathway essential for migration and provide novel mechanistic insights explaining dasatinib-related platelet dysfunction and bleeding.
Collapse
Affiliation(s)
- Rainer Kaiser
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Afra Anjum
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Lisa Kammerer
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Quentin Loew
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Anastassia Akhalkatsi
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Dario Rossaro
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Raphael Escaig
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Augustin Droste zu Senden
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Ben Raude
- Department of Vascular Surgery, Charité–Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Michael Lorenz
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
| | - Christoph Gold
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Kami Pekayvaz
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Thomas Brocker
- Institute for Immunology, Biomedical Center, Medical Faculty, Ludwig-Maximilian University Munich, Munich, Germany
| | - Jan Kranich
- Institute for Immunology, Biomedical Center, Medical Faculty, Ludwig-Maximilian University Munich, Munich, Germany
| | - Julian Walter Holch
- Department of Medicine III, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
- Comprehensive Cancer Center, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
- German Cancer Consortium, Partner Site Munich and German Cancer Research Centre, Heidelberg, Germany
| | - Karsten Spiekermann
- Department of Medicine III, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
- Comprehensive Cancer Center, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
- German Cancer Consortium, Partner Site Munich and German Cancer Research Centre, Heidelberg, Germany
| | - Steffen Massberg
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Florian Gaertner
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| | - Leo Nicolai
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany
- German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
| |
Collapse
|
10
|
Nicolai L, Kaiser R, Stark K. Thrombo-inflammation in Long COVID - the elusive key to post-infection sequelae? J Thromb Haemost 2023:S1538-7836(23)00400-2. [PMID: 37178769 PMCID: PMC10174338 DOI: 10.1016/j.jtha.2023.04.039] [Citation(s) in RCA: 15] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Revised: 03/18/2023] [Accepted: 04/10/2023] [Indexed: 05/15/2023]
Abstract
Long COVID is a public health emergency affecting millions of people worldwide, characterized by heterogenous symptoms across multiple organs systems. Here, we discuss the current evidence linking thrombo-inflammation to Post-acute sequelae of COVID-19 (PASC). Studies have found persistence of vascular damage with increased circulating markers of endothelial dysfunction, coagulation abnormalities with increased thrombin generation capacity, and abnormalities in platelet counts in PASC. Neutrophil phenotype resembles acute COVID-19 with an increase in activation and NETosis. These insights are potentially linked by elevated platelet-neutrophil aggregate formation. This hypercoagulable state in turn can lead to microvascular thrombosis, evidenced by microclots and elevated D-Dimer in the circulation, as well as perfusion abnormalities in the lung and brain of Long COVID patients. Also, COVID-19 survivors suffer from an increased rate of arterial and venous thrombotic events. We discuss three important, potentially intertwined hypotheses, that might contribute to thromboinflammation in Long COVID: Lasting structural changes, most prominently endothelial damage, caused during initial infection, a persistent viral reservoir, and immunopathology driven by a misguided immune system. Lastly, we outline the necessity for large, well-characterized clinical cohorts and mechanistic studies to clarify the contribution of thromboinflammation to Long COVID.
Collapse
Affiliation(s)
- Leo Nicolai
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany.
| | - Rainer Kaiser
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany
| | - Konstantin Stark
- Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilian University, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany
| |
Collapse
|
11
|
Bauer A, Pachl E, Hellmuth JC, Kneidinger N, Heydarian M, Frankenberger M, Stubbe HC, Ryffel B, Petrera A, Hauck SM, Behr J, Kaiser R, Scherer C, Deng L, Teupser D, Ahmidi N, Muenchhoff M, Schubert B, Hilgendorff A. Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. Biochim Biophys Acta Mol Basis Dis 2023; 1869:166592. [PMID: 36328146 PMCID: PMC9622026 DOI: 10.1016/j.bbadis.2022.166592] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Revised: 10/27/2022] [Accepted: 10/27/2022] [Indexed: 11/05/2022]
Abstract
SARS-CoV-2 remains an acute threat to human health, endangering hospital capacities worldwide. Previous studies have aimed at informing pathophysiologic understanding and identification of disease indicators for risk assessment, monitoring, and therapeutic guidance. While findings start to emerge in the general population, observations in high-risk patients with complex pre-existing conditions are limited. We addressed the gap of existing knowledge with regard to a differentiated understanding of disease dynamics in SARS-CoV-2 infection while specifically considering disease stage and severity. We biomedically characterized quantitative proteomics in a hospitalized cohort of COVID-19 patients with mild to severe symptoms suffering from different (co)-morbidities in comparison to both healthy individuals and patients with non-COVID related inflammation. Deep clinical phenotyping enabled the identification of individual disease trajectories in COVID-19 patients. By the use of the individualized disease phase assignment, proteome analysis revealed a severity dependent general type-2-centered host response side-by-side with a disease specific antiviral immune reaction in early disease. The identification of phenomena such as neutrophil extracellular trap (NET) formation and a pro-coagulatory response characterizing severe disease was successfully validated in a second cohort. Together with the regulation of proteins related to SARS-CoV-2-specific symptoms identified by proteome screening, we not only confirmed results from previous studies but provide novel information for biomarker and therapy development.
Collapse
Affiliation(s)
- Alina Bauer
- Helmholtz Zentrum München, Computational Health Department, Member of the German Center for Lung Research (DZL), 85764 Munich, Germany
| | - Elisabeth Pachl
- Helmholtz Zentrum München, Computational Health Department, Member of the German Center for Lung Research (DZL), 85764 Munich, Germany,Fraunhofer IKS, Fraunhofer Institute for Cognitive Systems IKS, 80686 Munich, Germany
| | - Johannes C. Hellmuth
- Department of Medicine III, University Hospital, LMU Munich, Munich, Germany,German Cancer Consortium (DKTK), Munich, Germany,COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany
| | - Nikolaus Kneidinger
- Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany,Department of Medicine V, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
| | | | - Marion Frankenberger
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany
| | - Hans C. Stubbe
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany,Department of Medicine II, University Hospital, LMU Munich, Munich, Germany
| | - Bernhard Ryffel
- Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans and Artimmune, Orléans, France
| | - Agnese Petrera
- Metabolomics and Proteomics Core, Helmholtz Zentrum München, Munich, Germany
| | - Stefanie M. Hauck
- Metabolomics and Proteomics Core, Helmholtz Zentrum München, Munich, Germany
| | - Jürgen Behr
- Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany,Department of Medicine V, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
| | - Rainer Kaiser
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany,Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany,DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Clemens Scherer
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany,Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany,DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Li Deng
- Helmholtz Zentrum München, Computational Health Department, Member of the German Center for Lung Research (DZL), 85764 Munich, Germany,Institute of Virology, Technical University of Munich, 81675 Munich, Germany
| | - Daniel Teupser
- Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Narges Ahmidi
- Fraunhofer IKS, Fraunhofer Institute for Cognitive Systems IKS, 80686 Munich, Germany
| | - Maximilian Muenchhoff
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany,Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany,German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
| | - Benjamin Schubert
- Helmholtz Zentrum München, Computational Health Department, Member of the German Center for Lung Research (DZL), 85764 Munich, Germany,Department of Mathematics, Technical University of Munich, 85748 Garching bei München, Germany
| | - Anne Hilgendorff
- Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany; Center for Comprehensive Developmental Care (CDeC(LMU)) at the Interdisciplinary Social Pediatric Center (iSPZ), LMU Hospital, Munich, Germany.
| |
Collapse
|
12
|
Erber J, Schneider J, Kaiser R, Spinner CD. [COVID-19 Update]. MMW Fortschr Med 2023; 165:58-61. [PMID: 36703066 PMCID: PMC9879616 DOI: 10.1007/s15006-022-2232-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- Johanna Erber
- Technische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Klinik und Poliklinik für Innere Medizin II,, Ismaninger Str. 22, 81675, München, Deutschland
| | - Jochen Schneider
- Technische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Klinik und Poliklinik für Innere Medizin II,, Ismaninger Str. 22, 81675, München, Deutschland
| | - Rainer Kaiser
- Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland
| | - Christoph D Spinner
- II. Medizinische Klinik und Poliklinik, Klinikum rechts d. Isar d. TU München, Ismaninger Straße 22, 81675, München, Deutschland
| |
Collapse
|
13
|
Makeľ M, Sukop A, Waldauf P, Whitley A, Hora A, Kaiser R. The effect of smoking and elderly age on digital replantation - a multivariate analysis. Acta Chir Plast 2023; 65:54-58. [PMID: 37722900 DOI: 10.48095/ccachp202354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/20/2023]
Abstract
INTRODUCTION It is often questioned whether to perform replantation or revision amputation for amputation injuries in elderly patients and smokers. According to the current indication criteria, neither old age nor smoking in the absence of other risk factors are considered to be risk factors for replantation failure. However, many microsurgeons still may make the decision not to perform digital replantation based solely on these factors. MATERIAL AND METHODS In order to evaluate the influence of both factors, we provided univariate and multivariate analyses of patients who underwent replantation at our centre during a 10-year period. We divided patients in two groups according to age (< and ≥ 60 years) and smoking status. RESULTS In the univariate analysis, there were no differences in immediate results between the two age groups. In the multivariate analysis, no statistical difference was found in neither long-term nor short-term results between the two age groups and between smokers and non-smokers. CONCLUSION Smoking and age should not be considered the only risk factors when deciding whether to perform digital replantation.
Collapse
|
14
|
Kaiser R, Kantorová L, Langaufová A, Slezáková S, Tučková D, Klugar M, Klézl Z, Barsa P, Cienciala J, Hajdúk R, Hrabálek L, Kučera R, Netuka D, Prýmek M, Repko M, Smrčka M, Štulík J. [Surgical Treatment of Degenerative Lumbar Stenosis and Spondylolisthesis: Clinical Practice Guideline]. Acta Chir Orthop Traumatol Cech 2023; 90:157-167. [PMID: 37395422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 07/04/2023]
Abstract
PURPOSE OF THE STUDY This article presents the evidence and the rationale for the recommendations for surgical treatment of degenerative lumbar stenosis (DLS) and spondylolisthesis that were recently developed as a part of the Czech Clinical Practice Guideline (CPG) "The Surgical Treatment of the Degenerative Diseases of the Spine". MATERIAL AND METHODS The Guideline was drawn up in line with the Czech National Methodology of the CPG Development, which is based on the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. We used an innovative GRADE-adolopment method that combines adoption and adaptation of the existing guidelines with de novo development of recommendations. In this paper, we present three adapted recommendations on DLS and a recommendation on spondylolisthesis developed de novo by the Czech team. RESULTS Open surgical decompression in DLS patients has been evaluated in three randomized controlled trials (RCTs). A recommendation in favour of decompression was made based on a statistically significant and clinically evident improvement in the Oswestry Disability Index (ODI) and leg pain. Decompression may be recommended for patients with symptoms of DLS in the event of correlation of significant physical limitation and the finding obtained via imaging. The authors of a systematic review of observational studies and one RCT conclude that fusion has a negligible role in the case of a simple DLS. Thus, spondylodesis should only be chosen as an adjunct to decompression in selected DLS patients. Two RCTs compared supervised rehabilitation with home or no exercise, showing no statistically significant difference between the procedures. The guideline group considers the post-surgery physical activity beneficial and suggests supervised rehabilitation in patients who have undergone surgery for DLS for the beneficial effects of exercise in the absence of known adverse effects. Four RCTs were found comparing simple decompression and decompression with fusion in patients with degenerative lumbar spondylolisthesis. None of the outcomes showed clinically significant improvement or deterioration in favour of either intervention. The guideline group concluded that for stable spondylolisthesis the results of both methods are comparable and, when other parameters are considered (balance of benefits and risks, or costs), point in favour of simple decompression. Due to the lack of scientific evidence, no recommendation has been formulated regarding unstable spondylolisthesis. The certainty of the evidence was rated as low for all recommendations. DISCUSSION Despite the unclear definition of stable/unstable slip, the inclusion of apparently unstable cases of DS in stable studies limits the conclusions of the studies. Based on the available literature, however, it can be summarized that in simple degenerative lumbar stenosis and static spondylolisthesis, fusion of the given segment is not justified. However, its use in the case of unstable (dynamic) vertebral slip is undisputable for the time being. CONCLUSIONS The guideline development group suggests decompression in patients with DLS in whom previous conservative treatment did not lead to improvement, spondylodesis only in selected patients, and post-surgical supervised rehabilitation. In patients with degenerative lumbar stenosis and spondylolisthesis with no signs of instability, the guideline development group suggests simple decompression (without fusion). Key words: degenerative lumbar stenosis, degenerative spondylolisthesis, spinal fusion, Clinical Practice Guideline, GRADE, adolopment.
Collapse
Affiliation(s)
- R Kaiser
- Neurochirurgická a neuroonkologická klinika 1. lékařské fakulty Univerzity Karlovy a Ústřední vojenské nemocnice, Praha
| | - L Kantorová
- České národní centrum Evidence-Based Healthcare a Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institut biostatistiky a analýz, Lékařská fakulta, Masarykova univerzita, Brno
- Agentura pro zdravotnický výzkum České republiky, Praha
| | - A Langaufová
- České národní centrum Evidence-Based Healthcare a Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institut biostatistiky a analýz, Lékařská fakulta, Masarykova univerzita, Brno
- Ústav zdravotnických informací a statistiky České republiky, Praha
| | - S Slezáková
- České národní centrum Evidence-Based Healthcare a Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institut biostatistiky a analýz, Lékařská fakulta, Masarykova univerzita, Brno
- Agentura pro zdravotnický výzkum České republiky, Praha
- Ústav zdravotnických informací a statistiky České republiky, Praha
| | - D Tučková
- České národní centrum Evidence-Based Healthcare a Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institut biostatistiky a analýz, Lékařská fakulta, Masarykova univerzita, Brno
- Agentura pro zdravotnický výzkum České republiky, Praha
| | - M Klugar
- České národní centrum Evidence-Based Healthcare a Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institut biostatistiky a analýz, Lékařská fakulta, Masarykova univerzita, Brno
- Agentura pro zdravotnický výzkum České republiky, Praha
- Ústav zdravotnických informací a statistiky České republiky, Praha
| | - Z Klézl
- Klinika spondylochirurgie 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
| | - P Barsa
- Neurochirurgické oddělení, Neurocentrum, Krajská nemocnice Liberec, Liberec
| | - J Cienciala
- Ortopedická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno, Brno
| | - R Hajdúk
- Klinika spondylochirurgie 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
| | - L Hrabálek
- Neurochirurgická klinika Lékařské fakulty Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc
| | - R Kučera
- Neurochirurgické oddělení, Nemocnice Na Homolce, Praha
| | - D Netuka
- Neurochirurgická a neuroonkologická klinika 1. lékařské fakulty Univerzity Karlovy a Ústřední vojenské nemocnice, Praha
| | - M Prýmek
- Ortopedická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno, Brno
| | - M Repko
- Ortopedická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno, Brno
| | - M Smrčka
- Neurochirurgická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno, Brno
| | - J Štulík
- Klinika spondylochirurgie 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
| |
Collapse
|
15
|
Grohé C, Wehler T, Henschke S, Dittrich I, Hammerschmidt S, Aulmann C, Dechow T, Schiefer C, von der Heyde E, Schuette W, Atz J, Kaiser R. 1143P Effect of best response to first-line (1L) treatment (tx) on outcomes with second-line (2L) nintedanib (NIN) + docetaxel (DOC) for patients (pts) with lung adenocarcinoma after 1L immune checkpoint inhibitor (ICI) combination therapy. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
16
|
Kaiser R, Escaig R, Erber J, Nicolai L. Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease. Front Cardiovasc Med 2022; 8:824112. [PMID: 35174225 PMCID: PMC8841491 DOI: 10.3389/fcvm.2021.824112] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2021] [Accepted: 12/31/2021] [Indexed: 12/16/2022] Open
Abstract
Neutrophils and platelets are among the most abundant cell types in peripheral blood and characterized by high plasticity and a readily available reservoir of surface proteins and secretable granule contents. Receptor-mediated activation and granule release predispose both cell types for rapid responses to various stimuli. While neutrophils provide the first line of defense to microbial infections and platelets are known for their aggregatory functions in hemostasis and thrombosis, research of the past decade has highlighted that both cell types jointly shape local and systemic immune responses and clot formation alike. Concomitant activation of neutrophils and platelets has been observed in a variety of cardiovascular diseases, including arterial and venous thrombosis, atherosclerosis as well as myocardial infarction and ischemia-reperfusion injury. In this review, we describe the mechanisms by which neutrophils and platelets interact physically, how release of granule contents and soluble molecules by either cell type affects the other and how this mutual activation supports the efficacy of immune responses. We go on to describe how activated platelets contribute to host defense by triggering neutrophil extracellular trap (NET) formation in a process termed immunothrombosis, which in turn promotes local platelet activation and coagulation. Further, we review current evidence of hazardous overactivation of either cell type and their respective role in cardiovascular disease, with a focus on thrombosis, myocardial infarction and ischemia-reperfusion injury, and describe how neutrophils and platelets shape thromboinflammation in COVID-19. Finally, we provide an overview of therapeutic approaches targeting neutrophil-platelet interactions as novel treatment strategy in cardiovascular disease.
Collapse
Affiliation(s)
- Rainer Kaiser
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK, German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Berlin, Germany
- *Correspondence: Rainer Kaiser
| | - Raphael Escaig
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK, German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Berlin, Germany
| | - Johanna Erber
- Department of Internal Medicine II, School of Medicine, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany
| | - Leo Nicolai
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK, German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Berlin, Germany
- Leo Nicolai
| |
Collapse
|
17
|
Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, Escaig R, Anjum A, Hoffknecht ML, Gold C, Brambs S, Engel A, Stockhausen S, Knottenberg V, Titova A, Haji M, Scherer C, Muenchhoff M, Hellmuth JC, Saar K, Schubert B, Hilgendorff A, Schulz C, Kääb S, Zimmer R, Hübner N, Massberg S, Mertins P, Nicolai L, Stark K. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 2021; 6:e150862. [PMID: 34403366 PMCID: PMC8492337 DOI: 10.1172/jci.insight.150862] [Citation(s) in RCA: 60] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Accepted: 08/11/2021] [Indexed: 12/15/2022] Open
Abstract
Neutrophils provide a critical line of defense in immune responses to various pathogens, inflicting self-damage upon transition to a hyperactivated, procoagulant state. Recent work has highlighted proinflammatory neutrophil phenotypes contributing to lung injury and acute respiratory distress syndrome (ARDS) in patients with coronavirus disease 2019 (COVID-19). Here, we use state-of-the art mass spectrometry-based proteomics and transcriptomic and correlative analyses as well as functional in vitro and in vivo studies to dissect how neutrophils contribute to the progression to severe COVID-19. We identify a reinforcing loop of both systemic and neutrophil intrinsic IL-8 (CXCL8/IL-8) dysregulation, which initiates and perpetuates neutrophil-driven immunopathology. This positive feedback loop of systemic and neutrophil autocrine IL-8 production leads to an activated, prothrombotic neutrophil phenotype characterized by degranulation and neutrophil extracellular trap (NET) formation. In severe COVID-19, neutrophils directly initiate the coagulation and complement cascade, highlighting a link to the immunothrombotic state observed in these patients. Targeting the IL-8-CXCR-1/-2 axis interferes with this vicious cycle and attenuates neutrophil activation, degranulation, NETosis, and IL-8 release. Finally, we show that blocking IL-8-like signaling reduces severe acute respiratory distress syndrome of coronavirus 2 (SARS-CoV-2) spike protein-induced, human ACE2-dependent pulmonary microthrombosis in mice. In summary, our data provide comprehensive insights into the activation mechanisms of neutrophils in COVID-19 and uncover a self-sustaining neutrophil-IL-8 axis as a promising therapeutic target in severe SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Rainer Kaiser
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Alexander Leunig
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
| | - Kami Pekayvaz
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Oliver Popp
- Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany
- DZHK, partner site Berlin, Berlin, Germany
| | - Markus Joppich
- Department of Informatics, Ludwig-Maximilians University Munich, Munich, Germany
| | - Vivien Polewka
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Raphael Escaig
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Afra Anjum
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Marie-Louise Hoffknecht
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Christoph Gold
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Sophia Brambs
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Anouk Engel
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Sven Stockhausen
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
| | - Viktoria Knottenberg
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Anna Titova
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
| | - Mohamed Haji
- Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany
- DZHK, partner site Berlin, Berlin, Germany
| | - Clemens Scherer
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Maximilian Muenchhoff
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
- Max von Pettenkofer Institute and GeneCenter, Virology, Faculty of Medicine, Ludwig-Maximilians University, Munich, Germany
- German Center for Infection Research, Partner Site Munich, Munich, Germany
| | - Johannes C. Hellmuth
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
- Medical Clinic and Polyclinic III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Kathrin Saar
- Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany
- DZHK, partner site Berlin, Berlin, Germany
| | - Benjamin Schubert
- Institute of Computational Biology, Helmholtz Zentrum München (German Research Center for Environmental Health), Neuherberg, Germany
- Department of Mathematics, Technical University of Munich, Garching, Germany
- The COMBAT C19IR study group is detailed in the Acknowledgments
| | - Anne Hilgendorff
- The COMBAT C19IR study group is detailed in the Acknowledgments
- Institute for Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Center Munich, Member of the German Center for Lung Research, Munich, Germany
- Center for Comprehensive Developmental Care at the interdisciplinary Social Pediatric Center, Haunersches Children’s Hospital, University Hospital Ludwig-Maximilian University, Munich, Germany
| | - Christian Schulz
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
| | - Stefan Kääb
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Ralf Zimmer
- Department of Informatics, Ludwig-Maximilians University Munich, Munich, Germany
| | - Norbert Hübner
- Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany
- DZHK, partner site Berlin, Berlin, Germany
- Charité-Universitätsmedizin Berlin, Germany
| | - Steffen Massberg
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Philipp Mertins
- Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany
- DZHK, partner site Berlin, Berlin, Germany
| | - Leo Nicolai
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| | - Konstantin Stark
- Department of Medicine I, University Hospital, Ludwig-Maximilians University Munich, Germany
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
| |
Collapse
|
18
|
Nicolai L, Kaiser R, Escaig R, Hoffknecht ML, Anjum A, Leunig A, Pircher J, Ehrlich A, Lorenz M, Ishikawa-Ankerhold H, Aird WC, Massberg S, Gaertner F. Single platelet and megakaryocyte morpho-dynamics uncovered by multicolor reporter mouse strains in vitro and in vivo. Haematologica 2021; 107:1669-1680. [PMID: 34525794 PMCID: PMC9244821 DOI: 10.3324/haematol.2021.278896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Indexed: 11/17/2022] Open
Abstract
Visualizing cell behavior and effector function on a single cell level has been crucial for understanding key aspects of mammalian biology. Due to their small size, large number and rapid recruitment into thrombi, there is a lack of data on fate and behavior of individual platelets in thrombosis and hemostasis. Here we report the use of platelet lineage restricted multi-color reporter mouse strains to delineate platelet function on a single cell level. We show that genetic labeling allows for single platelet and megakaryocyte (MK) tracking and morphological analysis in vivo and in vitro, while not affecting lineage functions. Using Cre-driven Confetti expression, we provide insights into temporal gene expression patterns as well as spatial clustering of MK in the bone marrow. In the vasculature, shape analysis of activated platelets recruited to thrombi identifies ubiquitous filopodia formation with no evidence of lamellipodia formation. Single cell tracking in complex thrombi reveals prominent myosin-dependent motility of platelets and highlights thrombus formation as a highly dynamic process amenable to modification and intervention of the acto-myosin cytoskeleton. Platelet function assays combining flow cytrometry, as well as in vivo, ex vivo and in vitro imaging show unaltered platelet functions of multicolor reporter mice compared to wild-type controls. In conclusion, platelet lineage multicolor reporter mice prove useful in furthering our understanding of platelet and MK biology on a single cell level.
Collapse
Affiliation(s)
- Leo Nicolai
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich.
| | - Rainer Kaiser
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | - Raphael Escaig
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | - Marie-Louise Hoffknecht
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | - Afra Anjum
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | - Alexander Leunig
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | - Joachim Pircher
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | | | | | | | - William C Aird
- Department of Medicine, Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, 02215, Massachusetts
| | - Steffen Massberg
- Department of Medicine I, University Hospital, LMU Munich; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, 80802 Munich
| | - Florian Gaertner
- Institute of Science and Technology (IST) Austria, 3400 Klosterneuburg.
| |
Collapse
|
19
|
Grohé C, Wehler T, Dechow T, Henschke S, Schütte W, Dittrich I, Hammerschmidt S, Müller-Huesmann H, Schumann C, Krüger S, Atz J, Kaiser R. 1330P Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
20
|
Kilbride P, Kaiser R, Lillegard J, Hench J, Hammerman M, Meneghel J. Improving post-thaw outcomes in primary human hepatocyte cryopreservation. Cytotherapy 2021. [DOI: 10.1016/s1465324921005223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Bernauer JC, Schmidt A, Henderson BS, Ice LD, Khaneft D, O'Connor C, Russell R, Akopov N, Alarcon R, Ates O, Avetisyan A, Beck R, Belostotski S, Bessuille J, Brinker F, Calarco JR, Carassiti V, Cisbani E, Ciullo G, Contalbrigo M, De Leo R, Diefenbach J, Donnelly TW, Dow K, Elbakian G, Eversheim PD, Frullani S, Funke C, Gavrilov G, Gläser B, Görrissen N, Hasell DK, Hauschildt J, Hoffmeister P, Holler Y, Ihloff E, Izotov A, Kaiser R, Karyan G, Kelsey J, Kiselev A, Klassen P, Krivshich A, Kohl M, Lehmann I, Lenisa P, Lenz D, Lumsden S, Ma Y, Maas F, Marukyan H, Miklukho O, Milner RG, Movsisyan A, Murray M, Naryshkin Y, Perez Benito R, Perrino R, Redwine RP, Rodríguez Piñeiro D, Rosner G, Schneekloth U, Seitz B, Statera M, Thiel A, Vardanyan H, Veretennikov D, Vidal C, Winnebeck A, Yeganov V. Measurement of the Charge-Averaged Elastic Lepton-Proton Scattering Cross Section by the OLYMPUS Experiment. Phys Rev Lett 2021; 126:162501. [PMID: 33961478 DOI: 10.1103/physrevlett.126.162501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 03/17/2021] [Accepted: 03/23/2021] [Indexed: 06/12/2023]
Abstract
We report the first measurement of the average of the electron-proton and positron-proton elastic scattering cross sections. This lepton charge-averaged cross section is insensitive to the leading effects of hard two-photon exchange, giving more robust access to the proton's electromagnetic form factors. The cross section was extracted from data taken by the OLYMPUS experiment at DESY, in which alternating stored electron and positron beams were scattered from a windowless gaseous hydrogen target. Elastic scattering events were identified from the coincident detection of the scattered lepton and recoil proton in a large-acceptance toroidal spectrometer. The luminosity was determined from the rates of Møller, Bhabha, and elastic scattering in forward electromagnetic calorimeters. The data provide some selectivity between existing form factor global fits and will provide valuable constraints to future fits.
Collapse
Affiliation(s)
- J C Bernauer
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Schmidt
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B S Henderson
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - L D Ice
- Arizona State University, Tempe, Arizona 85287, USA
| | - D Khaneft
- Johannes Gutenberg-Universität, Mainz, Germany
| | - C O'Connor
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R Russell
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - N Akopov
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - R Alarcon
- Arizona State University, Tempe, Arizona 85287, USA
| | - O Ates
- Hampton University, Hampton, Virginia 23668, USA
| | - A Avetisyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - R Beck
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - S Belostotski
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - J Bessuille
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - F Brinker
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - J R Calarco
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - V Carassiti
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - E Cisbani
- Istituto Nazionale di Fisica Nucleare sezione di Roma and Istituto Superiore di Sanità, Rome, Italy
| | - G Ciullo
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - M Contalbrigo
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - R De Leo
- Istituto Nazionale di Fisica Nucleare sezione di Bari, Bari, Italy
| | - J Diefenbach
- Hampton University, Hampton, Virginia 23668, USA
| | - T W Donnelly
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K Dow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Elbakian
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - P D Eversheim
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - S Frullani
- Istituto Nazionale di Fisica Nucleare sezione di Roma and Istituto Superiore di Sanità, Rome, Italy
| | - Ch Funke
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - G Gavrilov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - B Gläser
- Johannes Gutenberg-Universität, Mainz, Germany
| | - N Görrissen
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - D K Hasell
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J Hauschildt
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - Ph Hoffmeister
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - Y Holler
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - E Ihloff
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Izotov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - R Kaiser
- University of Glasgow, Glasgow, United Kingdom
| | - G Karyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - J Kelsey
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Kiselev
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - P Klassen
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - A Krivshich
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - M Kohl
- Hampton University, Hampton, Virginia 23668, USA
| | - I Lehmann
- University of Glasgow, Glasgow, United Kingdom
| | - P Lenisa
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - D Lenz
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - S Lumsden
- University of Glasgow, Glasgow, United Kingdom
| | - Y Ma
- Johannes Gutenberg-Universität, Mainz, Germany
| | - F Maas
- Johannes Gutenberg-Universität, Mainz, Germany
| | - H Marukyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - O Miklukho
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Movsisyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - M Murray
- University of Glasgow, Glasgow, United Kingdom
| | - Y Naryshkin
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | | | - R Perrino
- Istituto Nazionale di Fisica Nucleare sezione di Bari, Bari, Italy
| | - R P Redwine
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | | | - G Rosner
- University of Glasgow, Glasgow, United Kingdom
| | | | - B Seitz
- University of Glasgow, Glasgow, United Kingdom
| | - M Statera
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - A Thiel
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - H Vardanyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | | | - C Vidal
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Winnebeck
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - V Yeganov
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| |
Collapse
|
22
|
Barland S, Azam P, Lippi GL, Nyman RA, Kaiser R. Photon thermalization and a condensation phase transition in an electrically pumped semiconductor microresonator. Opt Express 2021; 29:8368-8375. [PMID: 33820285 DOI: 10.1364/oe.409344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Accepted: 02/13/2021] [Indexed: 06/12/2023]
Abstract
We report on an experimental study of photon thermalization and condensation in a semiconductor microresonator in the weak-coupling regime. We measure the dispersion relation of light and the photon mass in a single-wavelength, broad-area resonator. The observed luminescence spectrum is compatible with a room-temperature, thermal-equilibrium distribution. A phase transition, identified by a saturation of the population at high energies and a superlinear increase of the occupation at low energy, takes place when the phase-space density is of order unity. We explain our observations by Bose-Einstein condensation of photons in equilibrium with a particle reservoir and discuss the relation with laser emission.
Collapse
|
23
|
Cipris A, Moreira NA, do Espirito Santo TS, Weiss P, Villas-Boas CJ, Kaiser R, Guerin W, Bachelard R. Subradiance with Saturated Atoms: Population Enhancement of the Long-Lived States. Phys Rev Lett 2021; 126:103604. [PMID: 33784122 DOI: 10.1103/physrevlett.126.103604] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Accepted: 02/16/2021] [Indexed: 05/12/2023]
Abstract
Dipole-dipole interactions are at the origin of long-lived collective atomic states, often called subradiant, which are explored for their potential use in novel photonic devices or in quantum protocols. Here, we study subradiance beyond the single-excitation regime and experimentally demonstrate a 200-fold increase in the population of these modes, as the saturation parameter of the driving field is increased. We attribute this enhancement to a mechanism similar to optical pumping through the well-coupled superradiant states. The lifetimes are unaffected by the pump strength, as the system is ultimately driven toward the single-excitation sector. Our study is a new step in the exploration of the many-body dynamics of large open systems.
Collapse
Affiliation(s)
- A Cipris
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - N A Moreira
- Instituto de Física de São Carlos, Universidade de São Paulo, 13566-590 São Carlos, SP, Brazil
| | - T S do Espirito Santo
- Instituto de Física de São Carlos, Universidade de São Paulo, 13566-590 São Carlos, SP, Brazil
| | - P Weiss
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - C J Villas-Boas
- Departamento de Física, Universidade Federal de São Carlos, Rodovia Washington Luís, km 235-SP-310, 13565-905 São Carlos, SP, Brazil
| | - R Kaiser
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - W Guerin
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - R Bachelard
- Departamento de Física, Universidade Federal de São Carlos, Rodovia Washington Luís, km 235-SP-310, 13565-905 São Carlos, SP, Brazil
| |
Collapse
|
24
|
Nicolai L, Leunig A, Brambs S, Kaiser R, Joppich M, Hoffknecht ML, Gold C, Engel A, Polewka V, Muenchhoff M, Hellmuth JC, Ruhle A, Ledderose S, Weinberger T, Schulz H, Scherer C, Rudelius M, Zoller M, Keppler OT, Zwißler B, von Bergwelt-Baildon M, Kääb S, Zimmer R, Bülow RD, von Stillfried S, Boor P, Massberg S, Pekayvaz K, Stark K. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J Thromb Haemost 2021; 19:574-581. [PMID: 33217134 PMCID: PMC7753335 DOI: 10.1111/jth.15179] [Citation(s) in RCA: 65] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Revised: 11/04/2020] [Accepted: 11/10/2020] [Indexed: 12/30/2022]
Abstract
OBJECTIVE Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to severe pneumonia, but also thrombotic complications and non-pulmonary organ failure. Recent studies suggest intravascular neutrophil activation and subsequent immune cell-triggered immunothrombosis as a central pathomechanism linking the heterogenous clinical picture of coronavirus disease 2019 (COVID-19). We sought to study whether immunothrombosis is a pathognomonic factor in COVID-19 or a general feature of (viral) pneumonia, as well as to better understand its upstream regulation. APPROACH AND RESULTS By comparing histopathological specimens of SARS-CoV-2 with influenza-affected lungs, we show that vascular neutrophil recruitment, NETosis, and subsequent immunothrombosis are typical features of severe COVID-19, but less prominent in influenza pneumonia. Activated neutrophils were typically found in physical association with monocytes. To explore this further, we combined clinical data of COVID-19 cases with comprehensive immune cell phenotyping and bronchoalveolar lavage fluid scRNA-seq data. We show that a HLADRlow CD9low monocyte population expands in severe COVID-19, which releases neutrophil chemokines in the lungs, and might in turn explain neutrophil expansion and pulmonary recruitment in the late stages of severe COVID-19. CONCLUSIONS Our data underline an innate immune cell axis causing vascular inflammation and immunothrombosis in severe SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Leo Nicolai
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Alexander Leunig
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - Sophia Brambs
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
| | - Rainer Kaiser
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Markus Joppich
- Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | | | - Christoph Gold
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
| | - Anouk Engel
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
| | - Vivien Polewka
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
| | - Maximilian Muenchhoff
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
- Virology, Max von Pettenkofer Institute, Ludwig-Maximilians-Universität München, Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
| | - Johannes C Hellmuth
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
- Medizinische Klinik und Poliklinik III, University Hospital LMU Munich, Munich, Germany
- German Cancer Consortium (DKTK), Munich, Germany
| | - Adrian Ruhle
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
- Virology, Max von Pettenkofer Institute, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Stephan Ledderose
- Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Tobias Weinberger
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Heiko Schulz
- Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Clemens Scherer
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Martina Rudelius
- Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Michael Zoller
- Department of Anesthesiology, University Hospital, LMU, Munich, Germany
| | - Oliver T Keppler
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
- Virology, Max von Pettenkofer Institute, Ludwig-Maximilians-Universität München, Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
| | - Bernhard Zwißler
- Department of Anesthesiology, University Hospital, LMU, Munich, Germany
| | - Michael von Bergwelt-Baildon
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
- Medizinische Klinik und Poliklinik III, University Hospital LMU Munich, Munich, Germany
- German Cancer Consortium (DKTK), Munich, Germany
| | - Stefan Kääb
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Ralf Zimmer
- Department of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Roman D Bülow
- Institute of Pathology, University Clinic of RWTH, Aachen, Germany
| | | | - Peter Boor
- Institute of Pathology, University Clinic of RWTH, Aachen, Germany
- DeRegCOVID Registry
| | - Steffen Massberg
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Kami Pekayvaz
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| | - Konstantin Stark
- Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
- COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU, Munich, Germany
| |
Collapse
|
25
|
Cidrim A, do Espirito Santo TS, Schachenmayer J, Kaiser R, Bachelard R. Photon Blockade with Ground-State Neutral Atoms. Phys Rev Lett 2020; 125:073601. [PMID: 32857558 DOI: 10.1103/physrevlett.125.073601] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 07/13/2020] [Indexed: 06/11/2023]
Abstract
We show that induced dipole-dipole interactions allow for photon blockade in subwavelength ensembles of two-level, ground-state neutral atoms. Our protocol relies on the energy shift of the single-excitation, superradiant state of N atoms, which can be engineered to yield an effective two-level system. A coherent pump induces Rabi oscillation between the ground state and a collective bright state, with at most a single excitation shared among all atoms. The possibility of using clock transitions that are long-lived and relatively robust against stray fields, alongside new prospects on experiments with subwavelength lattices, makes our proposal a promising alternative for quantum information protocols.
Collapse
Affiliation(s)
- A Cidrim
- Departamento de Física, Universidade Federal de São Carlos, Rod. Washington Luís, km 235-SP-310, 13565-905 São Carlos, SP, Brazil
| | - T S do Espirito Santo
- Instituto de Física de São Carlos, Universidade de São Paulo-13560-970 São Carlos, SP, Brazil
| | - J Schachenmayer
- IPCMS (UMR 7504) and ISIS (UMR 7006), Université de Strasbourg, CNRS, 67000 Strasbourg, France
| | - R Kaiser
- Université de Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| | - R Bachelard
- Departamento de Física, Universidade Federal de São Carlos, Rod. Washington Luís, km 235-SP-310, 13565-905 São Carlos, SP, Brazil
- Université de Côte d'Azur, CNRS, Institut de Physique de Nice, 06560 Valbonne, France
| |
Collapse
|
26
|
Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, Muenchhoff M, Hellmuth JC, Ledderose S, Schulz H, Scherer C, Rudelius M, Zoller M, Höchter D, Keppler O, Teupser D, Zwißler B, von Bergwelt-Baildon M, Kääb S, Massberg S, Pekayvaz K, Stark K. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy. Circulation 2020; 142:1176-1189. [PMID: 32755393 PMCID: PMC7497892 DOI: 10.1161/circulationaha.120.048488] [Citation(s) in RCA: 370] [Impact Index Per Article: 92.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Supplemental Digital Content is available in the text. Background: Severe acute respiratory syndrome corona virus 2 infection causes severe pneumonia (coronavirus disease 2019 [COVID-19]), but the mechanisms of subsequent respiratory failure and complicating renal and myocardial involvement are poorly understood. In addition, a systemic prothrombotic phenotype has been reported in patients with COVID-19. Methods: A total of 62 subjects were included in our study (n=38 patients with reverse transcriptase polymerase chain reaction–confirmed COVID-19 and n=24 non–COVID-19 controls). We performed histopathologic assessment of autopsy cases, surface marker–based phenotyping of neutrophils and platelets, and functional assays for platelet, neutrophil functions, and coagulation tests, as well. Results: We provide evidence that organ involvement and prothrombotic features in COVID-19 are linked by immunothrombosis. We show that, in COVID-19, inflammatory microvascular thrombi are present in the lung, kidney, and heart, containing neutrophil extracellular traps associated with platelets and fibrin. Patients with COVID-19 also present with neutrophil-platelet aggregates and a distinct neutrophil and platelet activation pattern in blood, which changes with disease severity. Whereas cases of intermediate severity show an exhausted platelet and hyporeactive neutrophil phenotype, patients severely affected with COVID-19 are characterized by excessive platelet and neutrophil activation in comparison with healthy controls and non–COVID-19 pneumonia. Dysregulated immunothrombosis in severe acute respiratory syndrome corona virus 2 pneumonia is linked to both acute respiratory distress syndrome and systemic hypercoagulability. Conclusions: Taken together, our data point to immunothrombotic dysregulation as a key marker of disease severity in COVID-19. Further work is necessary to determine the role of immunothrombosis in COVID-19.
Collapse
Affiliation(s)
- Leo Nicolai
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Alexander Leunig
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Sophia Brambs
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany
| | - Rainer Kaiser
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Tobias Weinberger
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Michael Weigand
- Institute of Laboratory Medicine (M.W., D.T.), University Hospital Ludwig-Maximilian University Munich, Germany
| | - Maximilian Muenchhoff
- Virology, Max von Pettenkofer Institute (M.M., O.K.), Ludwig-Maximilian University Munich, Germany.,German Center for Infection Research (DZIF), Partner Site Munich (M.M., O.K.)
| | - Johannes C Hellmuth
- Medizinische Klinik und Poliklinik III (J.C.H., M.v.B.-B.), University Hospital Ludwig-Maximilian University Munich, Germany.,German Cancer Consortium (DKTK), Munich (J.C.H., M.v.B.-B.)
| | - Stephan Ledderose
- Institute of Pathology (S.L., H.S., M.R.), Ludwig-Maximilian University Munich, Germany
| | - Heiko Schulz
- Institute of Pathology (S.L., H.S., M.R.), Ludwig-Maximilian University Munich, Germany
| | - Clemens Scherer
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Martina Rudelius
- Institute of Pathology (S.L., H.S., M.R.), Ludwig-Maximilian University Munich, Germany
| | - Michael Zoller
- Department of Anesthesiology (M.Z., B.Z.), University Hospital Ludwig-Maximilian University Munich, Germany
| | | | - Oliver Keppler
- Virology, Max von Pettenkofer Institute (M.M., O.K.), Ludwig-Maximilian University Munich, Germany.,German Center for Infection Research (DZIF), Partner Site Munich (M.M., O.K.)
| | - Daniel Teupser
- Institute of Laboratory Medicine (M.W., D.T.), University Hospital Ludwig-Maximilian University Munich, Germany
| | - Bernhard Zwißler
- Department of Anesthesiology (M.Z., B.Z.), University Hospital Ludwig-Maximilian University Munich, Germany
| | - Michael von Bergwelt-Baildon
- Medizinische Klinik und Poliklinik III (J.C.H., M.v.B.-B.), University Hospital Ludwig-Maximilian University Munich, Germany.,German Cancer Consortium (DKTK), Munich (J.C.H., M.v.B.-B.)
| | - Stefan Kääb
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Steffen Massberg
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Kami Pekayvaz
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| | - Konstantin Stark
- Medizinische Klinik und Poliklinik I (L.N., A.L., S.B., R.K., T.W., C.S., S.K., S.M., K.P., K.S.), University Hospital Ludwig-Maximilian University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (L.N., A.L., R.K., T.W., C.S., S.K., S.M., K.P., K.S.)
| |
Collapse
|
27
|
Neuhann F, de Forest A, Heger E, Nhlema A, Scheller C, Kaiser R, Steffen HM, Tweya H, Fätkenheuer G, Phiri S. Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi. AIDS Res Ther 2020; 17:22. [PMID: 32434561 PMCID: PMC7240935 DOI: 10.1186/s12981-020-00282-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Accepted: 05/15/2020] [Indexed: 11/10/2022] Open
Abstract
Background Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment failure and the spread of drug resistant HIV variants. We assessed the prevalence of PDR and treatment outcomes among adults living with HIV-1 in Lilongwe, Malawi. Methods We selected 200 participants at random from the Lighthouse Tenofovir Cohort Study (LighTen). Serum samples were drawn prior to treatment initiation in 2014 and 2015, frozen, and later analyzed for the presence of HIV-1 drug resistance mutations. Amplicons were sequenced and interpreted by Stanford HIVdb interpretation algorithm 8.4. We assessed treatment outcomes by evaluating clinical outcome and viral suppression at the end of the follow-up period in October 2019. Results PDR testing was successful in 197 of 200 samples. The overall NNRTI- PDR prevalence was 13.7% (27/197). The prevalence of intermediate or high level NNRTI- PDR was 11.2% (22/197). The most common mutation was K103N (5.6%, 11/197), followed by Y181C (3.6%, 7/197). In one case, we detected an NRTI resistance mutation (M184V), in combination with multiple NNRTI resistance mutations. All HIV-1 isolates analyzed were of subtype C. Of the 27 patients with NNRTI- PDR, 9 were still alive, on ART, and virally suppressed at the end of follow-up. Conclusion The prevalence of NNRTI- PDR was above the critical level of 10% suggested by the Global Action Plan on HIV Drug Resistance. The distribution of drug resistance mutations was similar to that seen in previous studies from the region, and further supports the introduction of integrase inhibitors in first-line treatment in Malawi. Furthermore, our findings underline the need for continued PDR surveillance and pharmacovigilance in Sub-Saharan Africa.
Collapse
|
28
|
Kaiser R, Vaněk P, Saur K. Use of nuclear medicine methods in surgical treatment of lumbar spine degeneration. Rozhl Chir 2020; 99:46-50. [PMID: 32122139 DOI: 10.33699/pis.2020.99.1.46-50] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
INTRODUCTION Chronic back pain (CBP) is a very common symptom. Multiple modalities are used in its evaluation. However, according to current evidence, none of them can be used with certainty to predict the success of fusion surgery. Given the growing experience with bone tissue examination using the methods of nuclear medicine, we have used this possibility in patients with CBP without disc herniation, degenerative spinal stenosis or instability. CASE REPORTS We present case reports of 11 patients who underwent lumbar fusion (during two years period) for degenerative disc disease or facet arthropathy with adequate activity on PET or SPECT/CT examination. Rolland-Morris Questionnaire (RMQ), Oswestry Disability Index (ODI), and Visual Analogue Scale (VAS) were filled out pre-operatively and 24 months after surgery. RESULTS Six patients after one-level stabilization for active osteochondrosis and one for active facet arthropathy improved on average by 82% (64-92%) in RMQ, by 72% (48-100%) in ODI and 75% (55-100%) in VAS. Results in cases after multilevel stabilizations were slightly worse, but still very significant in most parameters. Only one patient with the most severe morphological and clinical findings did not benefit from surgery. CONCLUSION In 10 out of 11 patients, the lower back pain and quality of life improved significantly after lumbar fusion performed in levels diagnosed by PET or SPECT/CT. These methods certainly have their place in the evaluation of CBP, especially in the case of unclear findings or multiple degenerative changes.
Collapse
|
29
|
Abstract
The main goal of this comprehensive paper is to clarify the way of thoracolumbar spine The main goal of this summary paper is to describe the way of thoracolumbar spine injury classification development and to provide a detailed description of two of the most commonly used classifications - the Thoracolumbar Injury Classification and Severity Scale (TLICS) and the AOSpine Classification for Traumatic Fracture of the Thoracolumbar Spine, including their comparison and clarification of the merits introduced by the second one. The paper also formulates a recommendation of a simple algorithm enabling even less experienced clinicians to distinguish between an injury indicated for conservative treatment and one that requires surgery.
Collapse
|
30
|
Denis Page B, Carl M, Daniels D, Dominguez F, Essers ML, Hollman PCH, Rico II, Ito Y, Kaiser R, Kempf U, Kittle C, Lacroix G, Lombaert G, Miyata M, Pettipas R, Pocifia R, Willis C, Wong L. Liquid Chromatographic Method for the Determination of Nine Phenolic Antioxidants in Butter Oil: Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/76.4.765] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Ten laboratories collaboratively studied a liquid chromatographic (LC) method for the determination of propyl, octyl, and dodecyl gallate (PG, OG, and DG, respectively), 2,4,5-trihydroxybutyrophenone (THBP), ferf-butylhydroquinone (TBHQ), nordihydroguaiaretic acid (NDGA), 2- and 3-tert-butyl-4- hydroxyanisole (BHA), 2,6-di-ferf-butyl-4-hydroxymethylphenol (lonox-100), and 3,5-di-terf-butyl-4- hydroxytoluene (BHT) in butter oil. The 10 samples analyzed were spiked in matched pairs at about 100,50, and 10 μg/g. In the method studied, antioxidants are extracted as in AOAC LC method 983.15, but different LC eluants are used to separate the 9 antioxidants. Results from 1 laboratory were rejected as not valid and were not included in any calculations. For the remaining 9 laboratories, the overall mean recoveries for PG, THBP, TBHQ, NDGA, BHA, OG, lonox, BHT, and DG were 100.9, 97.8,103.4,95.4, 97.4,93.6,95.5,79.0, and 96.2%, respectively. The overall reproducibility relative standard deviations were 8.55,17.4,25.6,14.5,6.60, 9.64,10.8,11.4, and 7.35%, respectively. The method was adopted first action by AOAC International as a modification of AOAC method 983.15.
Collapse
Affiliation(s)
- B Denis Page
- Health and Welfare Canada, Health Protection Branch, Food Directorate, Bureau of Chemical Safety, Food Research Division, Ottawa, ON, Kl A 0L2, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Guerin W, Santo TSDE, Weiss P, Cipris A, Schachenmayer J, Kaiser R, Bachelard R. Collective Multimode Vacuum Rabi Splitting. Phys Rev Lett 2019; 123:243401. [PMID: 31922857 DOI: 10.1103/physrevlett.123.243401] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2019] [Indexed: 06/10/2023]
Abstract
We report the experimental observation of collective multimode vacuum Rabi splitting in free space. In contrast to optical cavities, the atoms couple to a continuum of modes, and the optical thickness of the cloud provides a measure of this coupling. The splitting, also referred as normal mode splitting, is monitored through the Rabi oscillations in the scattered intensity, and the results are fully explained by a linear-dispersion theory.
Collapse
Affiliation(s)
- W Guerin
- Université Côte d'Azur, CNRS, INPHYNI, F-06560 Valbonne, France
| | - T S do Espirito Santo
- Instituto de Física de São Carlos, Universidade de São Paulo, 13566-590 São Carlos, São Paulo, Brazil
- IPCMS (UMR 7504) and ISIS (UMR 7006), Université de Strasbourg, CNRS, 67000 Strasbourg, France
| | - P Weiss
- Université Côte d'Azur, CNRS, INPHYNI, F-06560 Valbonne, France
| | - A Cipris
- Université Côte d'Azur, CNRS, INPHYNI, F-06560 Valbonne, France
| | - J Schachenmayer
- IPCMS (UMR 7504) and ISIS (UMR 7006), Université de Strasbourg, CNRS, 67000 Strasbourg, France
| | - R Kaiser
- Université Côte d'Azur, CNRS, INPHYNI, F-06560 Valbonne, France
| | - R Bachelard
- Université Côte d'Azur, CNRS, INPHYNI, F-06560 Valbonne, France
- Departamento de Física, Universidade Federal de São Carlos, Rodovia Washington Luís, km 235-SP-310, 13565-905 São Carlos, São Paulo, Brazil
| |
Collapse
|
32
|
Grohe C, Gleiber W, Krüger S, Mueller-Huesmann H, Schulze M, Atz J, Kaiser R. Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz449.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Grohe C, Gleiber W, Haas S, Krüger S, Schulze M, Atz J, Kaiser R. Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated results of the ongoing non-interventional study (NIS) VARGADO. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
34
|
Cherroret N, Hemmerling M, Nador V, Walraven JTM, Kaiser R. Robust Coherent Transport of Light in Multilevel Hot Atomic Vapors. Phys Rev Lett 2019; 122:183203. [PMID: 31144888 DOI: 10.1103/physrevlett.122.183203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Indexed: 06/09/2023]
Abstract
Using a model system, we demonstrate both experimentally and theoretically that coherent scattering of light can be robust in hot atomic vapors despite a significant Doppler effect. By operating in a linear regime of far-detuned light scattering, we also unveil the emergence of interference triggered by inelastic Stokes and anti-Stokes transitions involving the atomic hyperfine structure.
Collapse
Affiliation(s)
- N Cherroret
- Laboratoire Kastler Brossel, Sorbonne Université, CNRS, ENS-PSL University, Collège de France, 4 Place Jussieu, 75005 Paris, France
| | - M Hemmerling
- Instituto de Física de São Carlos, Universidade de São Paulo, 13560-970 São Carlos, São Paulo, Brazil
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, Valbonne F-06560, France
| | - V Nador
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, Valbonne F-06560, France
| | - J T M Walraven
- Van der Waals-Zeeman Institute, Institute of Physics, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, The Netherlands
| | - R Kaiser
- Université Côte d'Azur, CNRS, Institut de Physique de Nice, Valbonne F-06560, France
| |
Collapse
|
35
|
Grohe C, Gleiber W, Haas S, Mueller-Huesmann H, Schulze M, Atz J, Kaiser R. Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz063.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Karimi S, Karimi S, Kaiser R, Cobbs E, Lepcha N, Whitehead S. Teaming up to Reduce Catheter-Associated Urinary Tract Infections. J Am Med Dir Assoc 2019. [DOI: 10.1016/j.jamda.2019.01.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
37
|
Grohe C, Gleiber W, Haas S, Mueller-Huesmann H, Schulze M, Atz J, Kaiser R. Efficacy and safety of nintedanib and docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First interim results of the ongoing non-interventional study VARGADO (NCT02392455). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy486.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Ruhi M, Lepcha N, Cobbs E, Kaiser R. CONFRONTING THE CHALLENGES OF HUNTINGTON’S DISEASE: THE IMPORTANCE OF PALLIATIVE TEAM AND FAMILY BASED CARE. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.1848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Ruhi
- Geriatrics and Palliative Medicine, George Washington University School of Medicine
| | - N Lepcha
- Geriatrics and Palliative Medicine, George Washington University School of Medicine
| | - E Cobbs
- Geriatrics and Palliative Medicine, George Washington University School of Medicine
| | - R Kaiser
- Geriatrics and Palliative Medicine, George Washington University School of Medicine
| |
Collapse
|
39
|
Grohe C, Zander I, Lüdtke-Heckenkamp K, Blau W, Krüger S, Franke C, Mueller-Huesmann H, Brückl W, Basara N, Ukena D, Lang S, Atz J, Kaiser R. Nintedanib plus docetaxel in routine clinical practice: VARGADO, a German prospective non-interventional study (NIS) reflecting routine treatment conditions in an evolving NSCLC treatment landscape. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.125] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Mokwa NF, Domröse C, Kaiser R, Steger G, Berthold G, Mallmann P. Akute maternale Maserninfektion unter Geburt. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- NF Mokwa
- Universitätsklinikum Köln, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Köln, Deutschland
| | - C Domröse
- Universitätsklinikum Köln, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Köln, Deutschland
| | - R Kaiser
- Universitätsklinikum Köln, Institut für Virologie, Köln, Deutschland
| | - G Steger
- Universitätsklinikum Köln, Institut für Virologie, Köln, Deutschland
| | - G Berthold
- Universitätsklinikum Köln, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Köln, Deutschland
| | - P Mallmann
- Universitätsklinikum Köln, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Köln, Deutschland
| |
Collapse
|
41
|
Abstract
SummaryStreptokinase-therapy is regularly followed by a marked increase of precipitating streptokinase-antibodies. These antibodies cause a significant inhibition of streptokinase-induced plasminogen activation. Counterelectrophoresis is a useful method of tracing the antibodies in serum. For quantitative estimation a modified radial immunodiffusion method is presented. The antibodies were identified as IgG.
Collapse
|
42
|
Eis-Hübinger AM, Sasowski U, Brackmann HH, Kaiser R, Matz B, Schneweis KE. Parvovirus B19 DNA Is Frequently Present in Recombinant Coagulation Factor VIII Products. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1650716] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
| | - U Sasowski
- The Institute of Medical Microbiology and Immunology, Germany
| | - H H Brackmann
- The Institute of Experimental Hematology and Transfusion Medicine of the Universitiy of Bonn, Germany
| | - R Kaiser
- The Institute of Medical Microbiology and Immunology, Germany
| | - B Matz
- The Institute of Medical Microbiology and Immunology, Germany
| | - K E Schneweis
- The Institute of Medical Microbiology and Immunology, Germany
| |
Collapse
|
43
|
Kupfer B, Oldenburg J, Brackmann HH, Matz B, Schneweis KE, Kaiser R. β-Propiolactone UV Inactivated Clotting Factor Concentrate Is the Source of HIV-Infection of 8 Hemophilia B Patients: Confirmed. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1649951] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- B Kupfer
- The Institut für Medizinische Mikrobiologie und Immunologie, Germany
| | - J Oldenburg
- The Institut für Experimentelle Hamatologie und Transfusionsmedizin of the University of Bonn, Germany
| | - H H Brackmann
- The Institut für Experimentelle Hamatologie und Transfusionsmedizin of the University of Bonn, Germany
| | - B Matz
- The Institut für Medizinische Mikrobiologie und Immunologie, Germany
| | - K E Schneweis
- The Institut für Medizinische Mikrobiologie und Immunologie, Germany
| | - R Kaiser
- The Institut für Medizinische Mikrobiologie und Immunologie, Germany
| |
Collapse
|
44
|
Große-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE. Serological and Virological Markers of Human Parvovirus B19 Infection in Sera of Hemophiliacs. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1648903] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryIt is known that parvovirus B19 (B19) is transmitted to hemophiliacs by clotting factors prepared from human plasma. However, it is not clear whether B19 is also transmitted by the more recently used inactivated clotting factor preparations. Therefore, we investigated 69 hemophiliacs, mostly children, receiving only virus-inactivated clotting factors. 49 of them (71%) were B19 IgG-positive and 18 of the IgG-positive hemophiliacs (37%) were also B19 IgM-positive. In contrast, out of 73 age-matched controls only 10 (14%) were IgG-positive, two of them being also IgM-positive. In hemophiliacs treated before 1984 with noninactivated clotting factors, seroprevalence was very similar: 94/136 (69%) presented B19 IgG antibodies as compared to their age-matched controls with 16/50 (32%). Out of the 94 IgG-positive patients 24 (26%) were IgM-positive, whereas IgM antibodies were never found in 16 sera of 16 IgG-positive controls. In 4 out of 24 IgM positive hemophiliacs, B19 DNA was detected in the sera by using the polymerase chain reaction. However, B19 DNA was also found in 3/69 anti-B19 IgM-negative, HIV-infected hemophiliacs (all three patients in CDC stage IV). Since it seems unlikely that the results only represent passive acquisition of B19 DNA from blood products and induction of antibodies by immunization with inactivated antigen, the observations rather suggest that infection with B19 is transmitted by clotting factors, including those treated for virus inactivation.
Collapse
Affiliation(s)
- A Große-Bley
- The institute of Medical Microbiology and Immunology, Munich, Germany
| | - A M Eis-Hübinger
- The institute of Medical Microbiology and Immunology, Munich, Germany
| | - R Kaiser
- The institute of Medical Microbiology and Immunology, Munich, Germany
| | - J Oldenburg
- The institute of Experimental Hematology and Transfusion Medicine, University of Bonn, Bonn, Germany
| | - H H Brackmann
- The institute of Experimental Hematology and Transfusion Medicine, University of Bonn, Bonn, Germany
| | - T F Schwarz
- The Max v. Pettenkofer Institute for Hygiene and Medical Microbiology, University of Munich, Munich, Germany
| | - K E Schneweis
- The institute of Medical Microbiology and Immunology, Munich, Germany
| |
Collapse
|
45
|
Gerritzen A, Scholt B, Kaiser R, Schneweis KE, Brackmann HH, Oldenburg J. Acute Hepatitis C in Haemophiliacs Due to “Virus-Inactivated” Clotting Factor Concentrates. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1646358] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- A Gerritzen
- Institute of Medical Microbiology and Immunology, University of Bonn, Sigmund Freud Str. 25, W-5300 Bonn 1, FRG
| | - B Scholt
- Institute of Medical Microbiology and Immunology, University of Bonn, Sigmund Freud Str. 25, W-5300 Bonn 1, FRG
| | - R Kaiser
- Institute of Medical Microbiology and Immunology, University of Bonn, Sigmund Freud Str. 25, W-5300 Bonn 1, FRG
| | - K E Schneweis
- Institute of Medical Microbiology and Immunology, University of Bonn, Sigmund Freud Str. 25, W-5300 Bonn 1, FRG
| | - H-H Brackmann
- Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Sigmund Freud Str. 25, W-5300 Bonn 1, FRG
| | - J Oldenburg
- Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Sigmund Freud Str. 25, W-5300 Bonn 1, FRG
| |
Collapse
|
46
|
Kaiser R. Meralgia paresthetica. Rozhl Chir 2018; 97:286-290. [PMID: 30442009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Meralgia paresthetica is a compression neuropathy of the lateral femoral cutaneous nerve. Despite its rarity, it is the most common nerve entrapment of the lower limbs. It produces similar symptoms as those associated with the more common L4 or L5 radiculopathy. Therefore, it is often diagnosed late (sometimes only after several years of latency) or not at all. This diagnosis should be considered especially in patients with obesity and diabetes who have chronic irritation of the ventrolateral areas of the thigh not responding to conservative therapy and a negative finding on lumbar MRI. We present our experience with surgical nerve decompression in three patients with pain, paresthesias, and sensory loss within the distribution of the lateral cutaneous nerve of the thigh. They all suffered from severe abdominal obesity. All conservative treatments, including weight reduction attempts, were unsuccessful. Nerve release caused an immediate effect in two cases. One patient experienced a temporary worsening of pain, which gradually improved within one month. In spite of the controversy surrounding the surgical treatment of meralgia (neurolysis or nerve resection), it can be concluded that nerve decompression has a good effect. Nerve resection is, in our view, considered to be a reserve option when primary surgery fails. Key words: meralgia paresthetica - nerve entrapment - peripheral nerve.
Collapse
|
47
|
Machekanyanga Z, Ndiaye S, Gerede R, Chindedza K, Chigodo C, Shibeshi ME, Goodson J, Daniel F, Zimmerman L, Kaiser R. Qualitative Assessment of Vaccination Hesitancy Among Members of the Apostolic Church of Zimbabwe: A Case Study. J Relig Health 2017; 56:1683-1691. [PMID: 28631171 PMCID: PMC5711523 DOI: 10.1007/s10943-017-0428-7] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Vaccine hesitancy or lack of confidence in vaccines is considered a threat to the success of vaccination programs. The rise and spread of measles outbreaks in southern Africa in 2009-2010 were linked to objections among Apostolic Church members, estimated at about 3.5 million in Zimbabwe as of 2014. To inform planning of interventions for a measles-rubella vaccination campaign, we conducted an assessment of the factors contributing to vaccine hesitancy using data from various stakeholders. Among nine districts in three regions of Zimbabwe, we collected data on religious attitudes toward, and perceptions of, vaccines through focus group discussions with health workers serving Apostolic communities and members of the National Expanded Programme on Immunization; semi-structured interviews with religious leaders; and open-ended questions in structured interviews with Apostolic parents/caregivers. Poor knowledge of vaccines, lack of understanding and appreciation of the effectiveness of vaccinations, religious teachings that emphasize prayers over the use of medicine, lack of privacy in a religiously controlled community, and low levels of education were found to be the main factors contributing to vaccine hesitancy among key community members and leaders. Accepting vaccination in public is a risk of sanctions. Poor knowledge of vaccines is a major factor of hesitancy which is reinforced by religious teachings on the power of prayers as alternatives. Because parents/caregivers perceive vaccines as dangerous for their children and believe they can cause death or disease, members of the Apostolic Church have more confidence in alternative methods such as use of holy water and prayers to treat diseases. Under these circumstances, it is important to debunk the myths about the power of holy water on the one hand and disseminate positive information of the efficacy of vaccines on the other hand in order to reduce hesitancy. Education about vaccines and vaccination in conjunction with government intervention, for example, through the use of social distancing policies can provide a framework for reducing hesitancy and increasing demand for vaccination.
Collapse
Affiliation(s)
- Z Machekanyanga
- Inter-country Support Team for East and Southern Africa, World Health Organization (WHO) Regional Office for Africa, Harare, Zimbabwe
| | - S Ndiaye
- Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Atlanta, GA, 30333, USA.
| | - R Gerede
- Ministry of Health and Child Care, Harare, Zimbabwe
| | | | - C Chigodo
- Ministry of Health and Child Care, Harare, Zimbabwe
| | - M E Shibeshi
- Inter-country Support Team for East and Southern Africa, World Health Organization (WHO) Regional Office for Africa, Harare, Zimbabwe
| | - J Goodson
- Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - F Daniel
- Inter-country Support Team for East and Southern Africa, World Health Organization (WHO) Regional Office for Africa, Harare, Zimbabwe
| | - L Zimmerman
- Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - R Kaiser
- Inter-country Support Team for East and Southern Africa, World Health Organization (WHO) Regional Office for Africa, Harare, Zimbabwe
- Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA
- Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Atlanta, GA, 30333, USA
| |
Collapse
|
48
|
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. HIV Med 2017; 19:65-71. [DOI: 10.1111/hiv.12532] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/06/2017] [Indexed: 11/29/2022]
Affiliation(s)
- SL Pett
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
- Institutes of Clinical Trials and Methodology; University College London; London UK
- Clinical Research Group; Infection and Population Health; Institute for Global Health; University College London; London UK
| | - J Amin
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
| | - A Horban
- Wojewodzki Szpital Zakazny Centre for AIDS therapy and Diagnosis; Warsaw Poland
| | | | - M Losso
- Hospital General de Agudos J M Ramos Mejia; Buenos Aires Argentina
- Fundación IBIS CICAL; Buenos Aires Argentina
| | | | - JS Madero
- Instituto Nacional de Ciencias Medicas y Nutriciòn Salvador Zubiran; Tlalpan Mexico
| | - W Belloso
- Fundación IBIS CICAL; Buenos Aires Argentina
- Hospital Italiano de Buenos Aires; Buenos Aires Argentina
| | - E Tu
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
| | - D Silk
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
| | - A Kelleher
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
- St Vincent's Hospital; Sydney NSW Australia
| | - R Harrigan
- BC Centre for Excellence in HIV/AIDS; Vancouver BC Canada
| | - A Clark
- ViiV Healthcare Ltd; London UK
| | | | - M Wolff
- Fundacion Arriaran; Santiago Chile
| | - J Gill
- Southern Alberta Clinic; Calgary AB Canada
| | - J Gatell
- Hospital Clinic de Barcelona; Barcelona Spain
| | - A Clarke
- Brighton & Sussex University Hospitals NHS Trust; Brighton UK
| | - K Ruxrungtham
- HIV-NAT; Thai Red Cross AIDS Research Center
- Chulalongkorn University; Bangkok Thailand
| | - T Prazuck
- Orleans Hospital (CHR Orleans La Source); Orleans France
| | - R Kaiser
- Institut für Virologie; Cologne Germany
| | - I Woolley
- Monash Medical Centre and Monash University; Melbourne Vic Australia
| | | | - D Cooper
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
- St Vincent's Hospital; Sydney NSW Australia
| | - JK Rockstroh
- Department of Medicine I; University Hospital Bonn; Bonn Germany
| | - P Mallon
- School of Medicine; University College Dublin; Dublin Ireland
| | - S Emery
- The Kirby Institute; UNSW Australia; Sydney NSW Australia
- Faculty of Medicine; The University of Queensland; Brisbane Qld Australia
| | | |
Collapse
|
49
|
Lesaffre E, Edelman M, Hanna N, Park K, Thatcher N, Willemsen S, Gaschler-Markefski B, Kaiser R, Manegold C. Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial. Ann Oncol 2017; 28:1419-1426. [DOI: 10.1093/annonc/mdx042] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Indexed: 11/13/2022] Open
|
50
|
Reck M, Staal-van den Brekel A, Mellemgaard A, Morsli N, Ellingboe AM, Kaiser R, Pietzko K, Kitzing T, Braunger J, Kerr K. A non-interventional biomarker study in patients (pts) with non-small cell lung cancer (NSCLC) of adenocarcinoma histology who are treated with nintedanib according to the approved label (LUME-BioNIS). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|